MIMPARA 90 mg, film-coated tablet 28 tablets
Active ingredients: Cinacalcet, Cinacalcet hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIMPARA 90 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 2 plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène PVC polyacétate de vinyle aluminium de 14 comprimé(s)
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68434003CIP73651643CIP133400936516434Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CINACALCETcomprimé | 90 mg · un comprimé | FT |
| CINACALCET (CHLORHYDRATE DE)comprimé | 99,18 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.